Chelerythrine was successfully micronized from methanol solution using Supercritical Carbon Dioxide (SC-CO 2 ) as an antisolvent via the Solution Enhanced Dispersion by Supercritical Fluids through the Prefilming Atomization (SEDS-PA) process. The morphology and particle size of the chelerythrine microparticles were visually analyzed by scanning electron microscopy (SEM). For the purpose of the optimizing operating conditions of the SEDS-PA process, the influences of the experimental variables, i.e., temperature, pressure, solution flow rate and initial solution concentration, on the particle size and morphology of chelerythrine microparticles are discussed in detail. The results show that the best process conditions for the micronization of chelerythrine are: T = 313 K, P = 20 MPa, C = 2.0 g/L and F = 2.0 mL/min. The precipitates obtained under the optimized experimental conditions are short rod-like chelerythrine microparticles with a mean particle size of 0.1-1 lm in width.
The environmentally benign Suzuki cross-coupling reaction was developed by using ScCO2(Supercritical CO2) instead of traditionally organic solvent. In the paper the compound phenylferrocene was synthesized by the Suzuki cross-coupling reaction of iodoferrocene and phenylboronic acids in ScCO2/PEG (polyethylene glycol) with excellent yield ratio in the presence of ligand-free Pd/C catalyst and K2CO3.1.5H2O as base. The Pd/C catalyst can be reused by simply washing sequence and CO2can be recycled after depressurization. The catalytic reaction conditions were optimized in the reaction using ScCO2as solvent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.